469
Views
11
CrossRef citations to date
0
Altmetric
Models

Immunohistochemical analysis of sympathetic involvement in the SOD1-G93A transgenic mouse model of amyotrophic lateral sclerosis

, , , , &
Pages 424-433 | Received 10 Jul 2012, Accepted 24 Feb 2013, Published online: 23 Apr 2013

References

  • Swash M. Clinical features and diagnosis of amyotrophic lateral sclerosis. In: Brown RH, Meininger V, Swash M, editors. Amyotrophic Lateral Sclerosis. London: Martin Dunitz; 2000. pp. 3–30.
  • Baltadzhieva R, Gurevich T, Korczyn AD. Autonomic impairment in amyotrophic lateral sclerosis. Curr Opin Neurol. 2005;18:487–93.
  • Kandinov B, Korczyn AD, Rabinowitz R, Nefussy B, Drory VE. Autonomic impairment in a transgenic mouse model of amyotrophic lateral sclerosis. Auton Neurosci. 2011;159:84–9.
  • Kandinov B, Drory VE, Tordjman K, Korczyn AD. Blood pressure measurements in a transgenic SOD1-G93A mouse model of amyotrophic lateral sclerosis. Amyotroph Lateral Scler. 2012;13:509–13.
  • Gibbins I. Peripheral autonomic pathways. In: Paxinos G, Mai J, editors. The Human Nervous System, 2nd edn. Oxford: Elsevier Academic; 2004. pp. 134–89.
  • Silverthorn DU. Human physiology: An integrated approach, 4th edn. Pearson/Benjamin Cummings; 2009. pp. 379–86.
  • Yoshimatsu H, Oomura Y, Katafuchi T, Niijima A. Effects of hypothalamic stimulation and lesion on adrenal nerve activity. Am J Physiol. 1987;253:418–24.
  • Deiana S, Platt B, Riedel G.. The cholinergic system and spatial learning. Behav Brain Res. 2011;221:389–411.
  • Masserano JM, Weiner N. Tyrosine hydroxylase regulation in the central nervous system. Mol Cell Biochem. 1983;54:129–52.
  • Gurney ME, Pu H, Chiu AY, Dal Canto MC, Polchow CY, Alexander DD, et al. Motor neuron degeneration in mice that express a human Cu/Zn superoxide dismutase mutation. Science. 1994;164:1772–5.
  • Lougheed R, Turnbull J. Lack of effect of methylene blue in the SOD1-G93A mouse model of amyotrophic lateral sclerosis. PLoS One. 2011;6:23141.
  • Clark D. Guide for the Care and Use of Laboratory Animals. 2nd edn. Washington, DC: National Academy Press; 1996.
  • Takahashi H, Oyanagi K, Ikuta F. The intermediolateral nucleus in sporadic amyotrophic lateral sclerosis. Acta Neuropathol (Berl). 1993;86:190–92.
  • Wong PC, Pardo CA, Borchelt DR, Lee MK, Copeland NG, Jenkins NA, et al. An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria. Neuron. 1995;14:1105–16.
  • Kong J, Xu Z. Massive mitochondrial degeneration in motor neurons triggers the onset of amyotrophic lateral sclerosis in mice expressing a mutant SOD1. J Neurosci. 1998;18:3241–50.
  • Carpenter S. Proximal axonal enlargement in motor neuron diseases. Neurology. 1968;18:841–51.
  • Sobue G, Hashizume Y, Yasuda T, Mukai E, Kumagai T, Mitsuma T, et al. Phosphorylated high molecular weight neurofilament protein in lower motor neurons in amyotrophic lateral sclerosis and other neurodegenerative diseases involving ventral horn cells. Acta Neuropathol. 1990;79: 402–8.
  • Boylan KB, Glass JD, Crook JE, Yang C, Thomas CS, Desaro P, et al. Phosphorylated neurofilament heavy subunit (pNF-H) in peripheral blood and CSF as a potential prognostic biomarker in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry 2012. In Press.
  • Keller BA, Volkening K, Droppelmann CA, Ang LC, Rademakers R, Strong MJ. Coaggregation of RNA binding proteins in ALS spinal motor neurons: evidence of a common pathogenic mechanism. Acta Neuropathol. 2012;124: 733–47.
  • Oey PL, Vos PE, Wieneke GH, Wokke JHJ, Blankestijn PJ, Karemaker JM. Subtle involvement of the sympathetic nervous system in amyotrophic lateral sclerosis. Muscle Nerve. 2002;25:402–8.
  • Shindo K, Watanabe H, Ohta E, Nagasaka T, Shiozawa Z, Takiyama Y. Sympathetic sudomotor neural function in amyotrophic lateral sclerosis. Amyotroph Lateral Scler. 2011;12:39–44.
  • Nakajima R, Takahashi K, Nakamura H, Otomo E, Kameyama M.. A quantitative study on the intermediolateral cells of the thoracic cord in degenerative diseases of the nervous system (author's transl). Rinsho Shinkeigaku. 1981;21:581–6.
  • Konno H, Yamamoto T, Iwasaki Y, Iizuka H. Shy-Drager syndrome and amyotrophic lateral sclerosis. Cytoarchitectonic and morphometric studies of sacral autonomic neurons. J Neurol Sci. 1986;73:193–204.
  • Itoh T, Sobue G, Ken E, Mitsuma T, Takahashi A, Trojanowski JQ. Phosphorylated high molecular weight neurofilament protein in the peripheral motor, sensory and sympathetic neuronal perikarya: system-dependent normal variations and changes in amyotrophic lateral sclerosis and multiple system atrophy. Acta Neuropathol. 1992;83: 240–5.
  • Asai H, Hirano M, Udaka F, Shimada K, Oda M, Kubori T, et al. Sympathetic disturbances increase risk of sudden cardiac arrest in sporadic ALS. J Neurol Sci. 2007;254:78–83.
  • Shimizu T, Kawata A, Kato S, Hayashi M, Takamoto K, Hayashi H, et al. Autonomic failure in ALS with a novel SOD1 gene mutation. Neurology. 2000;54:1534–7.
  • Shimizu T, Hayashi H, Kato S, Hayashi M, Tanabe H, Oda MI. Circulatory collapse and sudden death in respirator-dependent amyotrophic lateral sclerosis. J Neurol Sci. 1994;124:45–55.
  • Kasa P, Dobo E, Wolff JR. Cholinergic innervation of the mouse SCG: light and electron microscopic immunocytochemistry for choline acetyltransferase. Cell Tissue Res. 1991;265:151–8.
  • Lindh B, Staines W, Hökfelt T, Terenius L, Salvaterra PM.. Immunohistochemical demonstration of cholineacetyltransferase-immunoreactive preganglionic nerve fibres in guinea-pig autonomic ganglia. Proc Natl Acad Sci USA. 1986;83:5316–20.
  • Moura E, Costa DMP, Moura D, Guimaraes S, Vieira- Coelho MA. Decreased tyrosine hydroxylase activity in the adrenals of SHR. Life Science. 2005;76:2953–64.
  • Ulus IH, Wurtman RJ. Selective response of rat peripheral sympathetic nervous system to various stimuli. J Physiol. 1979;293:513–23.
  • Patrick RL, Kirshner N. Developmental changes in rat adrenal tyrosine hydroxylase, dopamine-β-hydroxylase and catecholamine levels: effect of denervation. Devel Biol. 1972;29:204–13.
  • Druschky A, Spitzer A, Platsch G, Claus D, Feistel H, Druschky K, et al. Cardiac sympathetic denervation in early stages of amyotrophic lateral sclerosis demonstrated by 123I-MIBGSPECT. Acta Neurol Scand. 1999;9:308–14.
  • Chida K, Sakamaki S, Takasu T. Alteration in autonomic function and cardiovascular regulation in amyotrophic lateral sclerosis. Neurology. 1989;236:127–30.
  • Ohno T, Shimizu T, Sato S, Hayashi H, Hirai S. Effect of tamsulosin hydrochloride on sympathetic hyperactivity in amyotrophic lateral sclerosis. Auton Neurosci. 2001;88: 94–8.
  • Yamashita A, Koike Y, Takahashi A, Hirayama M, Murakami N, Sobue G. Relationship between respiratory failure and plasma noradrenaline levels in amyotrophic lateral sclerosis. Clin Auton Res. 1997;7:173–7.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.